共 20 条
[1]
[Anonymous], 1997, ENCY CANC
[2]
BERENBAUM MC, 1977, CLIN EXP IMMUNOL, V28, P1
[3]
BERENBAUM MC, 1989, PHARMACOL REV, V41, P93
[4]
CHOU J, 1987, DOSE EFFECT ANAL MIC
[5]
Chou T., 1987, NEW AVENUES DEV CANC, V8, P37
[6]
GENERALIZED EQUATIONS FOR THE ANALYSIS OF INHIBITIONS OF MICHAELIS-MENTEN AND HIGHER-ORDER KINETIC SYSTEMS WITH 2 OR MORE MUTUALLY EXCLUSIVE AND NON-EXCLUSIVE INHIBITORS
[J].
EUROPEAN JOURNAL OF BIOCHEMISTRY,
1981, 115 (01)
:207-216
[7]
CHOU TC, 1974, MOL PHARMACOL, V10, P235
[8]
COMPUTERIZED QUANTITATION OF SYNERGISM AND ANTAGONISM OF TAXOL, TOPOTECAN, AND CISPLATIN AGAINST HUMAN TERATOCARCINOMA CELL-GROWTH - A RATIONAL APPROACH TO CLINICAL PROTOCOL DESIGN
[J].
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE,
1994, 86 (20)
:1517-1524